Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash from Financing Activities (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Cash from Financing Activities for 8 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 119.17% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.6 million through Dec 2025, down 187.93% year-over-year, with the annual reading at -$5.6 million for FY2025, 187.93% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$1.2 million at SANUWAVE Health, up from -$4.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $6.5 million in Q4 2024, with the low at -$4.4 million in Q3 2025.
  • Average Cash from Financing Activities over 3 years is $498166.7, with a median of $101500.0 recorded in 2024.
  • The sharpest move saw Cash from Financing Activities surged 248.95% in 2024, then plummeted 922.99% in 2025.
  • Over 3 years, Cash from Financing Activities stood at $1.9 million in 2023, then soared by 248.95% to $6.5 million in 2024, then tumbled by 119.17% to -$1.2 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$1.2 million, -$4.4 million, and $161000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.